|
Current Events |
TRIUMF Sponsors "The Atom Smashers" at the Vancouver International Film Festival |
26 September 2008 |
In a world fascinated by particle accelerators, one movie is being sponsored by TRIUMF at the Vancouver International Film Festival (VIFF). |
|
|
Current Events |
TRIUMF Sponsors BODY WORLDS & The Brain |
17 September 2010 |
TRIUMF and our partners, the UBC Brain Research Centre, and MDS Nordion, are proud to showcase nuclear-medicine research through support and involvement in Science World's newest exhibition—BODY WORLDS & The Brain. |
|
|
|
TRIUMF Spotlight: Medical Cyclotron Operations |
|
|
|
|
|
TRIUMF Staff - Help Needed! |
|
|
|
|
Current Events |
TRIUMF Statement on Chalk River Developments |
13 December 2007 |
Canadian expertise in nuclear science and technology is in high demand when it comes to producing radioisotopes for medical purposes. As the recent events in Chalk River have shown, the world depends upon Canada for these capabilities. |
|
|
|
TRIUMF Statement on Chalk River Developments |
|
|
|
|
Headlines |
TRIUMF strikes landmark isotope deal to expand access to actinium-225 |
16 December 2020 |
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225, a valuable but scarce radioisotope with tremendous promise as a cancer treatment. |
|
|
Awards & Honours |
TRIUMF Student Awarded CERN Fellowship |
18 July 2013 |
Former
TRIUMF collaborator Chloé Malbrunot was recognized as a senior research fellow
with CERN’s ASACUSA collaboration that is studying anti-hydrogen. |
 |
|
Awards & Honours |
TRIUMF Student Earns UBC Arts Co-op of the Year |
19 January 2011 |
Each year, the UBC Arts Co-op Program recognizes an undergrad co-op student for outstanding achievement. This year the award recognized Meghan Magee for her work term at TRIUMF. |
|
|
Current Events |
TRIUMF Submits Plans for Medical Isotope Alternatives |
17 September 2009 |
This week, TRIUMF submitted two proposals on medical isotope alternatives to the CIHR in a bid to obtain operating grants for the development of alternative radio-pharmaceuticals for medical imaging. |
|
